Clinical Trial Update: Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms in Treatment-Resistant Schizophrenia: A Pilot Study [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pilot study assessing the safety and feasibility of nasal delivery of exosomes derived from human dental follicle mesenchymal stem cells to treat nega…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Human dental follicle mesenchymal stem cell-derived exosomes

Snippet

Sponsor: Zigong Mental Health Center | Conditions: Schizophrenia Negative Type | EARLY_Phase 1 | Status: NOT_YET_RECRUITING